Silverarc Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Silverarc Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,536	Closed	-$144K	–	81
2024 Q3	$144K	Sell	1,536 -7,812	-84%	-$740K	0.03%	70
2024 Q2	$921K	Buy	9,348 +7,620	+441%	+$950K	0.22%	58
2024 Q1	$265K	Buy	+1,728	New	+$186K	0.07%	72
2021 Q1	–	Sell	-97	Closed	-$552K	–	102
2020 Q4	$552K	Buy	+97	New	+$610K	0.32%	69

Other funds holding YARW

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Silverarc Capital Management's YARW Position: Q4 2024 in Review

Silverarc Capital Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q4 2024, closing a stake of 1,536 shares — an estimated $144K sold.

Silverarc Capital Management first reported a position in YARW in Q4 2020 and held it in 4 quarters. The position peaked at $921K in Q2 2024. 34 funds tracked by Wall St. Rank hold YARW as of Q4 2024.

Silverarc Capital Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Silverarc Capital Management sold 1,536 Yarrow Bioscience, Inc. Common Stock shares in Q4 2024, an estimated $144K.
Silverarc Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Silverarc Capital Management's Yarrow Bioscience, Inc. Common Stock position peaked at $921K in Q2 2024.
34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q4 2024.

Based on Silverarc Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.